The present invention relates to a preparation method for a polyunsaturated fatty acid-calcium, primarily comprising directly reacting a polyunsaturated fatty acid material with a water-soluble calcium compound to obtain a polyunsaturated fatty acid-calcium salt. The present invention has a simple technical process, short reaction time, and high reaction yield. The produced polyunsaturated fatty acid-calcium product is of high quality, and relatively less byproducts and waste water are produced. The process is overall environmentally friendly and has small safety risks, and is suitable for scaled production.

Aromatic farnesyl compound and application of a pharmaceutical salt thereof as an inhibitor of α-glucosidase, dipeptidyl peptidase-4, aldose reductase, protein tyrosine phosphatase-1B or HMG-CoA reductase, or use thereof in preparing medicine and functional healthcare products having a liver protective function and/or for treating and/or preventing type II diabetes, diabetic retinopathy, diabetic foot disease, and hyperlipidemia.

The invention relates to the compounds of formula I and formula II or its pharmaceutical acceptable polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical compositions comprising an effective amount of salts of formula I or formula II; and methods for treating or preventing multiple sclerosis may be formulated for oral, buccal, rectal, topical, transdermal, transmucosal, intravenous, parenteral administration, syrup, or injection. Such compositions may be used to treatment of neurodegenerative diseases and psoriasis.

The invention relates to the compounds of formula I and formula II or its pharmaceutical acceptable polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical compositions comprising an effective amount of salts of formula I or formula II; and methods for treating or preventing multiple sclerosis may be formulated for oral, buccal, rectal, topical, transdermal, transmucosal, intravenous, parenteral administration, syrup, or injection. Such compositions may be used to treatment of neurodegenerative diseases and psoriasis.

A process for producing a composition having a ratio by weight of C.sub.10-C.sub.26 monobranched fatty acids or alkyl esters thereof to C.sub.10-C.sub.26 polybranched fatty acids or alkyl esters thereof of greater than 6 using a zeolite, preferably ferrierite, isomerization catalyst. The zeolite catalyst is preferably the only isomerization catalyst used. The zeolite catalyst can be reused many times after simple separation from the reaction products without having to be regenerated.

A process for producing a composition having a ratio by weight of C.sub.10-C.sub.26 monobranched fatty acids or alkyl esters thereof to C.sub.10-C.sub.26 polybranched fatty acids or alkyl esters thereof of greater than 6 using a zeolite, preferably ferrierite, isomerization catalyst. The zeolite catalyst is preferably the only isomerization catalyst used. The zeolite catalyst can be reused many times after simple separation from the reaction products without having to be regenerated.

The present disclosure provides a versatile process for producing valuable renewable hydrocarbons from triglyceride containing feedstock. The triglyceride containing feedstock is first split to provide a mixture containing fatty acids, glycerol and water, from which a phase separation provides an oily phase, and an aqueous phase. The oily phase containing fatty acids is subjected to fractionation, whereby specific fractions may be refined to products with controlled hydroprocessing. Products may contain paraffinic renewable aviation fuel components, paraffinic renewable base oil, renewable paraffinic diesel fuel components, renewable paraffinic technical fluid, or any combination thereof.

The present disclosure provides a versatile process for producing valuable renewable hydrocarbons from triglyceride containing feedstock. The triglyceride containing feedstock is first split to provide a mixture containing fatty acids, glycerol and water, from which a phase separation provides an oily phase, and an aqueous phase. The oily phase containing fatty acids is subjected to fractionation, whereby specific fractions may be refined to products with controlled hydroprocessing. Products may contain paraffinic renewable aviation fuel components, paraffinic renewable base oil, renewable paraffinic diesel fuel components, renewable paraffinic technical fluid, or any combination thereof.

The present invention relates to a process for carbonylating allyl alcohols at low temperature, low pressure and/or low catalyst loading. In an alternative embodiment, an acylation product of the allyl alcohol is used for the carbonylation. The present invention likewise relates to the preparation of conversion products of these carbonylation products and specifically of (−)-ambrox.

The present invention relates to a process for carbonylating allyl alcohols at low temperature, low pressure and/or low catalyst loading. In an alternative embodiment, an acylation product of the allyl alcohol is used for the carbonylation. The present invention likewise relates to the preparation of conversion products of these carbonylation products and specifically of (−)-ambrox.